Interpace Diagnostics Group Stock Price, News & Analysis (NASDAQ:IDXG)

$1.22 0.01 (0.83 %)
(As of 11/18/2017 11:17 AM ET)
Previous Close$1.22
Today's Range$1.25 - $1.18
52-Week Range$0.70 - $19.80
Volume713,345 shs
Average Volume1.04 million shs
Market Capitalization$32.76 million
P/E Ratio0.43
Dividend YieldN/A
Beta1.62

About Interpace Diagnostics Group (NASDAQ:IDXG)

Interpace Diagnostics Group logoInterpace Diagnostics Group, Inc., formerly PDI, Inc., is focused on developing and commercializing molecular diagnostic tests principally focused on early detection of high potential progressors to cancer and leveraging the latest technology and personalized medicine for patient diagnosis and management. The Company operates through molecular diagnostics segment. It offers molecular tests, such as PancraGen, which is a pancreatic cyst molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its PathFinder platform; ThyGenX, which assesses thyroid nodules for risk of malignancy, and ThyraMIR, which assesses thyroid nodules risk of malignancy utilizing a gene expression assay. Through its molecular diagnostics business, the Company provides diagnostic options for detecting genetic and other molecular alterations that are associated with gastrointestinal and endocrine cancers, which are focused on early detection of cancer.


Industry, Sector and Symbol:
  • Industry: Business Support Services
  • Sub-Industry: Health Care Services
  • Sector: Medical
  • Symbol: NASDAQ:IDXG
  • CUSIP: 69329V10
  • Web: www.interpacediagnostics.com
Debt:
  • Current Ratio: 1.90%
  • Quick Ratio: 1.69%
Price-To-Earnings:
  • Trailing P/E Ratio: 0.43
Sales & Book Value:
  • Annual Sales: $13.09 million
  • Price / Sales: 2.50
  • Book Value: $1.35 per share
  • Price / Book: 0.90
Profitability:
  • Trailing EPS: $2.99
  • Net Income: ($8,330,000.00)
  • Net Margins: -6.33%
  • Return on Equity: -5.69%
  • Return on Assets: -3.06%
Misc:
  • Employees: 61
  • Outstanding Shares: 26,850,000
 

Frequently Asked Questions for Interpace Diagnostics Group (NASDAQ:IDXG)

What is Interpace Diagnostics Group's stock symbol?

Interpace Diagnostics Group trades on the NASDAQ under the ticker symbol "IDXG."

How were Interpace Diagnostics Group's earnings last quarter?

Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) announced its quarterly earnings results on Thursday, August, 10th. The business services provider reported ($0.65) earnings per share for the quarter. The business services provider had revenue of $3.86 million for the quarter. Interpace Diagnostics Group had a negative net margin of 6.33% and a negative return on equity of 5.69%. View Interpace Diagnostics Group's Earnings History.

Where is Interpace Diagnostics Group's stock going? Where will Interpace Diagnostics Group's stock price be in 2017?

1 analysts have issued 12 month target prices for Interpace Diagnostics Group's shares. Their predictions range from $5.00 to $5.00. On average, they anticipate Interpace Diagnostics Group's share price to reach $5.00 in the next year. View Analyst Ratings for Interpace Diagnostics Group.

Who are some of Interpace Diagnostics Group's key competitors?

Who are Interpace Diagnostics Group's key executives?

Interpace Diagnostics Group's management team includes the folowing people:

  • Stephen J. Sullivan, Chairman of the Board (Age 70)
  • Jack E. Stover CPA, President, Chief Executive Officer, Director (Age 64)
  • James Early, Chief Financial Officer, Principal Financial Officer, Principal Accounting Officer (Age 63)
  • Felice Schnoll-Sussman, Director
  • Joseph D. Keegan Ph.D., Independent Director (Age 64)

How do I buy Interpace Diagnostics Group stock?

Shares of Interpace Diagnostics Group can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Interpace Diagnostics Group's stock price today?

One share of Interpace Diagnostics Group stock can currently be purchased for approximately $1.22.

How big of a company is Interpace Diagnostics Group?

Interpace Diagnostics Group has a market capitalization of $32.76 million and generates $13.09 million in revenue each year. The business services provider earns ($8,330,000.00) in net income (profit) each year or $2.99 on an earnings per share basis. Interpace Diagnostics Group employs 61 workers across the globe.

How can I contact Interpace Diagnostics Group?

Interpace Diagnostics Group's mailing address is MORRIS CORPORATE CENTER 1 BUILDING A 300 INTERPACE PARKWAY, PARSIPPANY NJ, 07054. The business services provider can be reached via phone at 844-405-9655 or via email at [email protected]


MarketBeat Community Rating for Interpace Diagnostics Group (NASDAQ IDXG)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  72 (Vote Outperform)
Underperform Votes:  62 (Vote Underperform)
Total Votes:  134
MarketBeat's community ratings are surveys of what our community members think about Interpace Diagnostics Group and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Interpace Diagnostics Group (NASDAQ:IDXG)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 1 Buy Rating, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $5.00 (309.84% upside)

Consensus Price Target History for Interpace Diagnostics Group (NASDAQ:IDXG)

Price Target History for Interpace Diagnostics Group (NASDAQ:IDXG)

Analysts' Ratings History for Interpace Diagnostics Group (NASDAQ:IDXG)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/14/2017Maxim GroupReiterated RatingBuy$5.00N/AView Rating Details
(Data available from 11/19/2015 forward)

Earnings

Earnings History and Estimates Chart for Interpace Diagnostics Group (NASDAQ:IDXG)

Earnings by Quarter for Interpace Diagnostics Group (NASDAQ:IDXG)

Earnings History by Quarter for Interpace Diagnostics Group (NASDAQ IDXG)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/10/2017Q2 2017($0.65)$3.86 millionViewN/AView Earnings Details
5/15/2017Q1 2017$0.42$3.47 millionViewN/AView Earnings Details
11/12/2015Q3($0.40)($0.31)$32.35 million$36.60 millionViewListenView Earnings Details
8/13/2015Q215($0.46)($0.44)$32.62 million$34.10 millionViewListenView Earnings Details
5/12/2015Q115($0.48)($0.25)$33.20 million$38.30 millionViewListenView Earnings Details
3/3/2015Q414($0.50)($0.27)$140.87 million$28.90 millionViewListenView Earnings Details
11/3/2014Q3($0.19)($0.29)$33.40 million$29.20 millionViewListenView Earnings Details
8/13/2014Q2($0.12)($0.17)$35.60 million$31.60 millionViewListenView Earnings Details
5/7/2014Q1($0.11)($0.11)$39.48 million$32.80 millionViewListenView Earnings Details
2/27/2014Q4($0.11)($0.25)$38.09 million$36.41 millionViewListenView Earnings Details
11/12/2013Q3($0.23)($0.14)ViewListenView Earnings Details
8/5/2013Q2 2013($0.11)($0.06)$35.26 million$37.20 millionViewListenView Earnings Details
3/6/2013Q4 2012($0.07)($1.64)$36.90 million$35.60 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Interpace Diagnostics Group (NASDAQ:IDXG)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Interpace Diagnostics Group (NASDAQ:IDXG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Interpace Diagnostics Group (NASDAQ IDXG)

Insider Ownership Percentage: 0.70%
Institutional Ownership Percentage: 7.15%
Insider Trades by Quarter for Interpace Diagnostics Group (NASDAQ:IDXG)
Institutional Ownership by Quarter for Interpace Diagnostics Group (NASDAQ:IDXG)

Insider Trades by Quarter for Interpace Diagnostics Group (NASDAQ IDXG)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/25/2014Graham G MiaoCFOBuy22,000$1.65$36,300.00View SEC Filing  
11/10/2014Nancy LurkerCEOBuy49,000$1.75$85,750.00View SEC Filing  
11/7/2014Gerald R Melillo JrInsiderBuy5,000$1.58$7,900.00View SEC Filing  
11/7/2014Jeffrey Edward SmithVPBuy200,000$1.75$350,000.00View SEC Filing  
11/6/2014Nancy LurkerCEOBuy57,000$1.74$99,180.00View SEC Filing  
11/5/2014Gerald P BelleDirectorBuy57,300$1.71$97,983.00View SEC Filing  
11/18/2013Gerald BelleDirectorBuy20,400$5.21$106,284.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Interpace Diagnostics Group (NASDAQ IDXG)

Source:
DateHeadline
Head-To-Head Analysis: Unifirst Corporation (UNF) versus Interpace Diagnostics Group (IDXG)Head-To-Head Analysis: Unifirst Corporation (UNF) versus Interpace Diagnostics Group (IDXG)
www.americanbankingnews.com - November 18 at 3:37 AM
BRIEF-Interpace Diagnostics says ‍New York State Department Of Health approved its TERT service offeringBRIEF-Interpace Diagnostics says ‍New York State Department Of Health approved its TERT service offering
www.reuters.com - November 17 at 6:40 PM
Interpace Diagnostics Announces New York State Approval of New ProductInterpace Diagnostics Announces New York State Approval of New Product
finance.yahoo.com - November 17 at 5:36 AM
Interpace Diagnostics Group, Inc. (IDXG) Rating Reiterated by Maxim GroupInterpace Diagnostics Group, Inc. (IDXG) Rating Reiterated by Maxim Group
www.americanbankingnews.com - November 14 at 1:14 PM
BRIEF-Interpace Diagnostics says Q3 sales up 27 pctBRIEF-Interpace Diagnostics says Q3 sales up 27 pct
www.reuters.com - November 14 at 12:51 AM
Edited Transcript of IDXG earnings conference call or presentation 13-Nov-17 1:30pm GMTEdited Transcript of IDXG earnings conference call or presentation 13-Nov-17 1:30pm GMT
finance.yahoo.com - November 14 at 12:51 AM
Interpace Diagnostics Groups (IDXG) CEO Jack Stover on Q3 2017 Results - Earnings Call Transcript - Seeking AlphaInterpace Diagnostics Group's (IDXG) CEO Jack Stover on Q3 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - November 13 at 7:49 PM
Interpace Diagnostics Group Reports Third Quarter 2017 Financial Results, Business Progress and Recent AccomplishmentsInterpace Diagnostics Group Reports Third Quarter 2017 Financial Results, Business Progress and Recent Accomplishments
finance.yahoo.com - November 13 at 7:49 PM
Interpace Diagnostics to Host Conference Call and Webcast to Discuss Third Quarter 2017 Financial Results and Business Progress on Monday November 13, 2017Interpace Diagnostics to Host Conference Call and Webcast to Discuss Third Quarter 2017 Financial Results and Business Progress on Monday November 13, 2017
finance.yahoo.com - November 11 at 11:14 AM
Ituran Location and Control (ITRN) & Interpace Diagnostics Group (IDXG) Financial ContrastIturan Location and Control (ITRN) & Interpace Diagnostics Group (IDXG) Financial Contrast
www.americanbankingnews.com - November 7 at 9:36 PM
Recent VRSK NewsRecent VRSK News
www.bloomberg.com - November 2 at 1:52 AM
Todays Research Report Coverage on Business Services Stocks -- Interpace Diagnostics, ITUS Corp., Marathon Patent, and Verisk AnalyticsToday's Research Report Coverage on Business Services Stocks -- Interpace Diagnostics, ITUS Corp., Marathon Patent, and Verisk Analytics
www.prnewswire.com - October 30 at 9:47 PM
NetworkNewsBreaks - VistaGen Therapeutics, Inc. VTGN Shares Surge on FDA Authorization to Commence Phase 2 Study of AV-101 for MDDNetworkNewsBreaks - VistaGen Therapeutics, Inc. VTGN Shares Surge on FDA Authorization to Commence Phase 2 Study of AV-101 for MDD
www.marketwatch.com - October 26 at 12:52 PM
Interpace Diagnostics Designated as “Company of the Month” by G2 IntelligenceInterpace Diagnostics Designated as “Company of the Month” by G2 Intelligence
finance.yahoo.com - October 26 at 12:52 PM
Interpace Diagnostics Presents Important Data at the World Congress of Gastroenterology at American College of ... - GlobeNewswire (press release)Interpace Diagnostics Presents Important Data at the World Congress of Gastroenterology at American College of ... - GlobeNewswire (press release)
globenewswire.com - October 23 at 9:26 PM
Interpace Diagnostics Presents Important Data at the World Congress of Gastroenterology at American College of Gastroenterology (ACG) 2017Interpace Diagnostics Presents Important Data at the World Congress of Gastroenterology at American College of Gastroenterology (ACG) 2017
finance.yahoo.com - October 23 at 4:26 PM
Interpace Diagnostics Presents New Data from Over 3,400 Patients Tested with ThyGenX®/ThyraMIR®Interpace Diagnostics Presents New Data from Over 3,400 Patients Tested with ThyGenX®/ThyraMIR®
finance.yahoo.com - October 19 at 3:46 AM
Atento (ATTO) & Interpace Diagnostics Group (IDXG) Head to Head ContrastAtento (ATTO) & Interpace Diagnostics Group (IDXG) Head to Head Contrast
www.americanbankingnews.com - October 15 at 8:28 PM
Contrasting Interpace Diagnostics Group (IDXG) & WageWorks (WAGE)Contrasting Interpace Diagnostics Group (IDXG) & WageWorks (WAGE)
www.americanbankingnews.com - October 14 at 8:36 AM
Interpace Diagnostics Announces Increased Reimbursement for ThyGenX®Interpace Diagnostics Announces Increased Reimbursement for ThyGenX®
finance.yahoo.com - October 12 at 6:18 AM
All You Need To Know About Interpace Diagnostics Group Inc’s (IDXG) RisksAll You Need To Know About Interpace Diagnostics Group Inc’s (IDXG) Risks
finance.yahoo.com - October 5 at 9:17 PM
Interpace Diagnostics to Present at The MicroCap Conference on October 5th in New York City at the Essex HouseInterpace Diagnostics to Present at The MicroCap Conference on October 5th in New York City at the Essex House
finance.yahoo.com - September 28 at 8:50 PM
Interpace debuts new lung cancer test that differentiates between recurrent/new disease; shares up 4%Interpace debuts new lung cancer test that differentiates between recurrent/new disease; shares up 4%
seekingalpha.com - September 26 at 10:42 AM
Financial Analysis: Interpace Diagnostics Group (IDXG) versus Cardtronics PLC (CATM)Financial Analysis: Interpace Diagnostics Group (IDXG) versus Cardtronics PLC (CATM)
www.americanbankingnews.com - September 26 at 12:28 AM
Interpace Diagnostics Group (IDXG) vs. Acacia Research Corporation (ACTG) Critical AnalysisInterpace Diagnostics Group (IDXG) vs. Acacia Research Corporation (ACTG) Critical Analysis
www.americanbankingnews.com - September 25 at 10:28 AM
Interpace Diagnostics Announces Expansion into New Clinical Area with Launch of Molecular Lung Cancer TestInterpace Diagnostics Announces Expansion into New Clinical Area with Launch of Molecular Lung Cancer Test
finance.yahoo.com - September 25 at 9:49 AM
Interpace Diagnostics’ CEO Interviewed on The RedChip Money ReportInterpace Diagnostics’ CEO Interviewed on The RedChip Money Report
finance.yahoo.com - September 22 at 1:54 PM
Power Distribution, Inc. Showcases Modular Compact RPP at DCD MexicoPower Distribution, Inc. Showcases Modular Compact RPP at DCD Mexico
feeds.benzinga.com - September 21 at 7:25 AM
Interpace Diagnostics Announces Receipt of Letter From Nasdaq Confirming Compliance With Audit Committee RequirementsInterpace Diagnostics Announces Receipt of Letter From Nasdaq Confirming Compliance With Audit Committee Requirements
finance.yahoo.com - September 20 at 4:08 PM
Interpace Diagnostics Group, Inc. (IDXG) Sees Large Increase in Short InterestInterpace Diagnostics Group, Inc. (IDXG) Sees Large Increase in Short Interest
www.americanbankingnews.com - September 16 at 2:14 AM
Interpace Diagnostics (IDXG) Appoints Dr. Felice Schnoll-Sussman to BoardInterpace Diagnostics (IDXG) Appoints Dr. Felice Schnoll-Sussman to Board
www.streetinsider.com - September 14 at 11:44 PM
Interpace Diagnostics Announces Appointment of New DirectorInterpace Diagnostics Announces Appointment of New Director
finance.yahoo.com - September 14 at 6:19 AM
BRIEF-Interpace Diagnostics Group Inc - ‍ assigned a new, discreet CPT code to facilitate reimbursement of ThyramirBRIEF-Interpace Diagnostics Group Inc - ‍ assigned a new, discreet CPT code to facilitate reimbursement of Thyramir
www.reuters.com - September 12 at 1:15 AM
Interpace Diagnostics (IDXG) Reports New CPT Code for Reimbursement of Molecular Thyroid TestInterpace Diagnostics (IDXG) Reports New CPT Code for Reimbursement of Molecular Thyroid Test
www.streetinsider.com - September 12 at 1:15 AM
Interpace Diagnostics Announces New CPT Code for Reimbursement of Molecular Thyroid TestInterpace Diagnostics Announces New CPT Code for Reimbursement of Molecular Thyroid Test
finance.yahoo.com - September 11 at 8:13 PM
 Interpace Diagnostics Group, Inc. (IDXG) Given $5.00 Average Price Target by Analysts Interpace Diagnostics Group, Inc. (IDXG) Given $5.00 Average Price Target by Analysts
www.americanbankingnews.com - September 10 at 4:10 PM
Comparing Interpace Diagnostics Group (IDXG) and its PeersComparing Interpace Diagnostics Group (IDXG) and its Peers
www.americanbankingnews.com - September 9 at 10:24 AM
Interpace Diagnostics Announces Participation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York CityInterpace Diagnostics Announces Participation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City
finance.yahoo.com - September 7 at 8:01 PM
Interpace Diagnostics Announces Receipt of Letter From Nasdaq Confirming Compliance With Minimum Closing Bid PriceInterpace Diagnostics Announces Receipt of Letter From Nasdaq Confirming Compliance With Minimum Closing Bid Price
finance.yahoo.com - August 31 at 7:46 PM
Interpace Diagnostics to Present at the 6th Annual Liolios Gateway Conference on September 6, 2017Interpace Diagnostics to Present at the 6th Annual Liolios Gateway Conference on September 6, 2017
finance.yahoo.com - August 31 at 7:46 PM
BRIEF-Interpace Diagnostics announces renewal and extension of LabCorp national agreementBRIEF-Interpace Diagnostics announces renewal and extension of LabCorp national agreement
www.reuters.com - August 29 at 5:25 AM
Interpace Diagnostics (IDXG) Announces Renewal and Extension Pact with LabCorp (LH)Interpace Diagnostics (IDXG) Announces Renewal and Extension Pact with LabCorp (LH)
www.streetinsider.com - August 29 at 5:25 AM
Earnings Review and Free Research Report: Priceline Group’s Adjusted Diluted EPS Increased 20% on a Y-o-Y BasisEarnings Review and Free Research Report: Priceline Group’s Adjusted Diluted EPS Increased 20% on a Y-o-Y Basis
finance.yahoo.com - August 28 at 7:21 PM
Interpace Diagnostics Announces Renewal and Extension of LabCorp National AgreementInterpace Diagnostics Announces Renewal and Extension of LabCorp National Agreement
finance.yahoo.com - August 28 at 7:21 PM
Interpace Diagnostics Group, Inc. :IDXG-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017Interpace Diagnostics Group, Inc. :IDXG-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
finance.yahoo.com - August 26 at 6:06 AM
Interpace Diagnostics (IDXG) Says Its Thyroid Test Will be Covered by Oxford Health PlansInterpace Diagnostics (IDXG) Says Its Thyroid Test Will be Covered by Oxford Health Plans
www.streetinsider.com - August 17 at 12:45 AM
Interpace Diagnostics Announces Coverage of Thyroid Test by Oxford Health PlansInterpace Diagnostics Announces Coverage of Thyroid Test by Oxford Health Plans
finance.yahoo.com - August 16 at 7:43 PM
3 Stocks You Must Know About Before Wednesdays Opening Bell3 Stocks You Must Know About Before Wednesday's Opening Bell
finance.yahoo.com - August 16 at 7:43 PM
Interpace Diagnostics Group, Inc. (IDXG) Coverage Initiated at Maxim GroupInterpace Diagnostics Group, Inc. (IDXG) Coverage Initiated at Maxim Group
www.americanbankingnews.com - August 15 at 6:40 PM
Head-To-Head Contrast: Brady Corporation (BRC) and Interpace Diagnostics Group (IDXG)Head-To-Head Contrast: Brady Corporation (BRC) and Interpace Diagnostics Group (IDXG)
www.americanbankingnews.com - August 15 at 2:20 AM

Social Media

Financials

Chart

Interpace Diagnostics Group (NASDAQ IDXG) Chart for Sunday, November, 19, 2017
Loading chart…

This page was last updated on 11/19/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.